EUCTR2009-014841-10-FR进行中（未招募）1 期
The Impact of LY2189265 versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus(AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3) - GBDC
Eli Lilly & Company - Indianapolis0 个研究点目标入组 753 人开始时间: 2010年4月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 753
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients diagnosed with type 2 diabetes for =3 months and =5 years, with a screening HbA1c =6.5% to =9.5%, and are
- •1) treatment naïve
- •2) not optimally treated with diet and exercise alone, and/or
- •3) on 1 oral antihyperglycemic medication.
- •Patients on oral antihyperglycemic medication (OAM) monotherapy must
- •be on a dose =50% of the recommended maximum daily dose (per the local label) at Visit 1 for =3 months.
- •See protocol for full details of inclusion criteria.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients who have type 1 diabetes; or who have been treated chronically with insulin therapy for the treatment of diabetes at any time in the past.
- •See protocol for full details of exclusion criteria.
研究者
相似试验
进行中（未招募）
1 期
A study in patients with Type 2 Diabetes mellitusType 2 Diabetes MellitusEUCTR2009-014841-10-GBEli Lilly & Company - Indianapolis753
进行中（未招募）
不适用
The Impact of LY2189265 versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus(AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3) - GBDCType 2 Diabetes MellitusEUCTR2009-014841-10-SKEli Lilly & Company - Indianapolis753
进行中（未招募）
不适用
A Study in Patients with Type 2 Diabetes MellitusDiabetes Mellitus Type 2MedDRA version: 14.0Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2009-014841-10-CZEli Lilly & Company753
进行中（未招募）
不适用
The Impact of LY2189265 versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus(AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3) - GBDCType 2 Diabetes MellitusEUCTR2009-014841-10-FIEli Lilly & Company - Indianapolis753
进行中（未招募）
不适用
The Impact of LY2189265 versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus(AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3) - GBDCMedDRA version: 13.1Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 Diabetes MellitusEUCTR2009-014841-10-DEEli Lilly & Company - Indianapolis753